Larvol Delta - MABCII047-Exploration-of-Dalpiciclib--Chidamide-in-HRHER2-Advanced-Breast-Cancer-After-Failure-of-CDK46-Inhibitor-a-Phase-b-Study

Epidaza (chidamide) - Chipscreen

AiRuiKang (dalpiciclib) - Jiangsu Hengrui Pharma

http://clinicaltrials.gov/ct2/show/NCT05586841

May 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next